Tag Archives: Sloan Kettering Cancer Center

Doctors' Stand Against Pricey Drugs: A Warning to Pharma?

By Amy Ritter. In a New York Times op-ed this week, a trio of physicians from the Memorial Sloan Kettering Cancer Center in New York announced their decision to remove an expensive new cancer treatment from the hospital formulary, citing cost-benefit as their reason. The physicians said that because Zaltrap (ziv-aflibercept) made by Sanofi/Regeneron was […]
Posted in Global | Also tagged | 1 Comment
  • Categories

  • Meta